Exane Derivatives’s Verint Systems VRNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-38
Closed -$1.96K 992
2022
Q1
$1.96K Buy
+38
New +$1.95K ﹤0.01% 753
2021
Q4
Sell
-38
Closed -$1.7K 1042
2021
Q3
$1.7K Hold
38
﹤0.01% 815
2021
Q2
$1.61K Buy
38
+27
+245% +$1.25K ﹤0.01% 830
2021
Q1
$500 Buy
+11
New +$492 ﹤0.01% 800
2020
Q2
Sell
-1,625
Closed -$35.6K 748
2020
Q1
$35.6K Buy
+1,625
New +$43.7K 0.01% 382

Other funds holding VRNT

Exane Derivatives's VRNT Position: Q2 2022 in Review

Exane Derivatives sold out of Verint Systems (VRNT) in Q2 2022, closing a stake of 38 shares — an estimated $1.96K sold.

Exane Derivatives first reported a position in VRNT in Q1 2020 and held it in 5 quarters. The position peaked at $35.6K in Q1 2020. 238 funds tracked by Wall St. Rank hold VRNT as of Q2 2022.

  • Exane Derivatives reported no remaining Verint Systems position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 38 Verint Systems shares in Q2 2022, an estimated $1.96K.
  • Exane Derivatives first reported a position in Verint Systems in Q1 2020 and held it in 5 quarters.
  • Exane Derivatives's Verint Systems position peaked at $35.6K in Q1 2020.
  • 238 funds tracked by Wall St. Rank held Verint Systems as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.